DomovBBN • SWX
add
Bellevue Group AG
Predch. zatv. cena
14,75 CHF
Denný rozsah
14,50 CHF - 14,80 CHF
Rozsah rokov
11,05 CHF - 24,30 CHF
Trhová kapitalizácia
195,19 mil. CHF
Priemerný objem
9,95 tis.
Cena/zisk
13,08
Dividendový výnos
7,93 %
Hlavná burza
SWX
Novinky na trhu
Finančné údaje
Výkaz ziskov a strát
Výnosy
Čisté príjmy
(CHF) | 6/2024info | Zmena medziročne |
---|---|---|
Výnosy | 18,41 mil. | -11,31 % |
Prevádzkové náklady | 13,73 mil. | -10,56 % |
Čisté príjmy | 3,72 mil. | -7,22 % |
Čistá zisková marža | 20,18 | 4,61 % |
Earnings per share | — | — |
Zisk pred zdanením, úrokmi, odpismi | — | — |
Skutočná daňová sadzba | 17,26 % | — |
Súvaha
Celkové aktíva
Celkové záväzky
(CHF) | 6/2024info | Zmena medziročne |
---|---|---|
Hotovosť a krátk. invest. | 30,49 mil. | 100,63 % |
Celkové aktíva | 138,75 mil. | -4,69 % |
Celkové záväzky | 22,05 mil. | -24,81 % |
Celkový kapitál | 116,70 mil. | — |
Shares outstanding | 13,20 mil. | — |
Pomer ceny a účt. hodnoty | 1,67 | — |
Rentabilita aktív | 10,71 % | — |
Rentabilita kapitálu | — | — |
Peňažný tok
Čistá zmena množstva peňažných prostriedkov
(CHF) | 6/2024info | Zmena medziročne |
---|---|---|
Čisté príjmy | 3,72 mil. | -7,22 % |
Prevádzkový peňažný tok | 3,65 mil. | 137,31 % |
Peniaze z investícií | — | — |
Peniaze z financovania | -8,10 mil. | 45,85 % |
Čistá zmena množstva peňažných prostriedkov | -4,17 mil. | 83,13 % |
Voľný peňažný tok | — | — |
Informácie
Bellevue Group AG, headquartered in Zurich, is a listed investment management corporation from Switzerland. Bellevue Group consists of the subsidiaries Bellevue Asset Management, Bellevue Private Markets and StarCapital. It has 9,6 billion Swiss francs Assets Under Management Around 80% of clients assets are in healthcare investments. Bellevue Group is also active in alternative investments and private equity, including co-investments in private domestic small and medium-sized enterprises. In this business area, client assets under management were 1.0 billion francs as of mid-2021.
Bellevue Group is among the largest investors in the health care segment worldwide. It has subsidiaries in Germany, UK and USA, and is focusing on platform companies with products in phase two trials or later who preferably develop technologies that can be applied in multiple ways. One of the Bellevue Asset Management teams manages the BB Biotech investment company. The former investment company BB Medtech, which was converted into an equity fund at the end of September 2009, is also managed by Bellevue Asset Management. Wikipedia
Generálny riaditeľ
Dátum založenia
1993
Web
Zamestnanci
88